|
|
According to a global consulting firm Pricewaterhousecooper, the growing number of chronic diseases with the economic growth can propel the country amongst the top pharmaceuticals market of the world by 2020. In the coming years, India is expected to host some of the largest number of cardiovascular and diabetic patients in the world. Also, these diseases will start at much younger age as compared to now. Irrespective of the increased spending on preventive medicines, the deteriorating health of young Indians would expand the pharma market. The number of Indians with diabetes is projected to reach 73.5 million in the next 10-15 years.
|
